Noangina 2.6mg Tablet CR
bottle of 30.0 tablet.Prescription required
About this product:
| Salt Composition: | Nitroglycerin (2.6mg) |
| Manufacturer: | Fujin Kami Pharmaceutico |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Noangina 2.6mg Tablet CR is used to treat and prevent heart-related chest pain (angina). Noangina 2.6mg Tablet CR should be taken in the dose and duration as advised by your doctor. It may be taken with or without food, preferably at a fixed time each day. Do not consume more than the recommended dose as this may have harmful effects on your body. You can develop tolerance to this medicine over time, which means that the same dose becomes less effective. You have to stick to a really specific dosing schedule to prevent this from happening.
Noangina 2.6mg Tablet CR is a nitrate. It works by relaxing the blood vessels and increasing the supply of blood and oxygen to the heart while reducing its work load, thereby preventing/treating attacks of angina (chest pain).
Can sildenafil be taken with Noangina 2.6mg Tablet CR?
No, taking sildenafil and Noangina 2.6mg Tablet CR together can cause a significant drop in blood pressure, which may be life-threatening. It is essential to avoid using these medications concurrently.
What effect does Noangina 2.6mg Tablet CR have on blood pressure?
Noangina 2.6mg Tablet CR lowers blood pressure by relaxing the blood vessels. However, it is not recommended for treating high blood pressure and may cause dizziness when changing positions suddenly due to its vasodilatory effect.
Does Noangina 2.6mg Tablet CR lose its effectiveness over time?
Yes, excessive use of Noangina 2.6mg Tablet CR can lead to tolerance, reducing its effectiveness. To maintain its efficacy, doctors typically prescribe the smallest dose required for treating acute angina attacks.
What are the potential consequences of taking too much Noangina 2.6mg Tablet CR?
Overdosing on Noangina 2.6mg Tablet CR can lead to severe symptoms, including low blood pressure, sweating, nausea, vomiting, headache, weak and fast pulse, dizziness, and fainting. Immediate medical attention is required in such cases.
Can I stop using Noangina 2.6mg Tablet CR once I feel better?
Abruptly stopping Noangina 2.6mg Tablet CR after prolonged use may trigger angina attacks. Consult your doctor to gradually taper off the medication over 4-6 weeks before discontinuing it entirely.
Does Noangina 2.6mg Tablet CR prevent heart attacks?
Noangina 2.6mg Tablet CR is prescribed to prevent episodes of angina in patients with coronary artery disease, where narrowed blood vessels supply the heart. The medication relaxes these vessels, reducing the workload on the heart and increasing oxygen supply.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Noangina 2.6mg Tablet CR may be taken with or without food, but it is better to take it at a fixed time.
- do not drive or do anything that requires concentration until you know how it affects you
- do not consume alcohol while taking Noangina 2.6mg Tablet CR as it may cause increased dizziness
- it may cause headaches which usually go away after a few days of continued treatment
- you may develop tolerance to Noangina 2.6mg Tablet CR with time
- stop taking medications (prescribed for erectile dysfunction) like sildenafil or tadalafil while on treatment with Noangina 2.6mg Tablet CR as it may cause low blood pressure
- headaches
- dizziness
- lightheadedness
Alcohol
Consuming alcohol while taking Noangina 2.6mg Tablet CR may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
Breastfeed
Noangina 2.6mg Tablet CR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnancy
Noangina 2.6mg Tablet CR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
